Literature DB >> 20821207

99mTc-tetrofosmin SPECT for the evaluation of cerebral lesions.

George A Alexiou, Andreas D Fotopoulos, Spyridon Tsiouris, Spyridon Voulgaris, Athanasios P Kyritsis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20821207     DOI: 10.1007/s00259-010-1602-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Evaluation of glioma proliferation by 99mTc-Tetrofosmin.

Authors:  George A Alexiou; Spyridon Tsiouris; Ann Goussia; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Andreas D Fotopoulos
Journal:  Neuro Oncol       Date:  2007-11-30       Impact factor: 12.300

2.  Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma.

Authors:  Dirk Hellwig; Ralf Ketter; Bernd F M Romeike; Andrea Schaefer; Georgios Farmakis; Aleksandar Grgic; Jean R Moringlane; Wolf-Ingo Steudel; Carl-Martin Kirsch; Samuel Samnick
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-30       Impact factor: 9.236

3.  Influence of glioma's multidrug resistance phenotype on (99m)Tc-tetrofosmin uptake.

Authors:  George A Alexiou; Anna Goussia; Athanasios P Kyritsis; Spyridon Tsiouris; Antigoni Ntoulia; Vassiliki Malamou-Mitsi; Spyridon Voulgaris; Andreas D Fotopoulos
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

4.  Correlation of glioma proliferation assessed by flow cytometry with (99m)Tc-Tetrofosmin SPECT uptake.

Authors:  George A Alexiou; Spyridon Tsiouris; George Vartholomatos; George Fotakopoulos; Athanasios Papadopoulos; Athanasios P Kyritsis; Spyridon Voulgaris; Andreas D Fotopoulos
Journal:  Clin Neurol Neurosurg       Date:  2009-09-01       Impact factor: 1.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.